期刊文献+

cⅠ期周围型NSCLC纵隔淋巴结廓清范围的临床研究 被引量:1

Metastasis of mediastinal lymph nodes in peripheral c-Ⅰ stage non-small cell lung cancer: a clinical study on reasonable dissection of mediastinal lymph nodes
下载PDF
导出
摘要 目的:探讨cⅠ期周围型非小细胞肺癌(nonsmall cell lung cancer,NSCLC)纵隔淋巴结合理的廓清范围。方法:回顾性研究196例行系统性纵隔淋巴结廓清的cⅠ期周围型NSCLC患者的临床资料,分析临床病理特征与纵隔淋巴结转移的关系。结果:28例患者术后病理证实为N2,占14.3%(28/196),腺癌、鳞癌患者的纵隔淋巴结转移的发生率分别为18.8%(22/117)、7.6%(6/79),两者相比差异有统计学意义,P=0.023。ⅠA期、ⅠB期患者的发生率分别为7.5%(5/67)、17.8%(23/129),两者相比差异有统计学意义,P=0.049。上叶肿瘤纵隔淋巴结转移80.0%在上纵隔,下叶肿瘤纵隔淋巴结转移76.5%在下纵隔,上、下叶肿瘤均可发生隆突下淋巴结转移。结论:cⅠ期周围型NSCLC应行包括隆突下淋巴结在内的选择性区域纵隔淋巴结廓清。 OBJECTIVE: To investigate the extent of mediastinal lymph nodes dissection in peripheral c-Ⅰ stage non-small cell lung cancer. METHODS: A retrospective study was carried out. Between January,1996 and June, 2003, 196 patients with peripheral c-Ⅰ stage non-small cell lung cancer underwent radical surgery and systemic mediastinal lymph nodes dissection. RESULTS: Among all the 196 patients, p-N2 was found in 28 patients (14.3%). The mediastinal lymph node metastasic rate of adenocarcinoma was 18.8%, and squamous cell carcinoma was 7.6%, P=0.023. The mediastinal lymph node metastasic rate of IA stage was 7.5%, and IB stage was 17.8%, P=0.049. Most of p-N2 disease were regional mediastinal nodal metastasis and surcarinal nodes. CONCLUSION: Regional mediastinal nodal and surcarinal nodal dissection should be routinely performed for clinical Stage Ⅰ peripheral non-small cell lung cancer.
出处 《肿瘤防治杂志》 2005年第11期850-852,共3页 China Journal of Cancer Prevention and Treatment
关键词 非小细胞肺癌 手术治疗 肿瘤转移 纵隔淋巴结 纵隔淋巴结廓清 carcinoma,non-small cell lung/surgery neoplasm metastasis/mediastinal lymph nodes mediastinal lymphadenectomy
  • 相关文献

参考文献7

  • 1吴一龙,王思愚,黄植蕃,区伟,杨学宁,余辉.Ⅰ~ⅢA期非小细胞肺癌淋巴结清扫范围的前瞻性研究[J].中华肿瘤杂志,2001,23(1):43-45. 被引量:69
  • 2Funatsu T, Matsubara Y, Ikeda S, et al. Preoperative mediastinoscopic assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer[J]. J Thorac Cardiovasc Surg, 1994,108(2):321-328.
  • 3Lewis J W Jr, Pearlery J L, Beute G H, et al. Can computed tomography of the chest stage lung cancer?-yes or no[J]. Ann Thorac Surg,1990,49(4):591-596.
  • 4Suzuki K, Nagai K,Yoshida J, et al.Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer[J]. J Thorac Cardiovasc Surg, 1999,177(3): 593-598.
  • 5Graham A N J, Chan K J M, Pastorino U, et al.Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer[J]. J Thorac Cardiovasc Surg,1999,117(2):246-251.
  • 6李玉,李厚文,胡永校,殷洪年,赵惠儒,陈东义.肺癌淋巴结转移规律的临床研究[J].中华胸心血管外科杂志,2000,16(1):10-12. 被引量:54
  • 7Okada M, Tsubota N, Yoshimru M, et al. Proposal for reasonabal mediastinal lymphadenectomy in bronchogenic carcinoma: role of subcarinal node in selective dissection[J]. J Thorac Cardiovasc Surg,1998,116(6):949-953.

二级参考文献5

共引文献116

同被引文献5

  • 1孔丽丽,霍萌,刘白鹭.肺癌胸内淋巴结转移的评价方法及研究进展[J].放射学实践,2007,22(1):102-103. 被引量:1
  • 2Lewis JW Jr, Pearlery JL, Beute GH,et al. Can computed tomography of the chest stage lung cancer? - yes or no [ J ]. Ann Thorae Surg,1990,49(4) :591.
  • 3Funatsu T, Matsubara Y, Ikeda S, et al. Preoperative mediastinoseopie assessment of N factors and the need for mediastinal lymph node dissection in T1 lung cancer[J]. J Thorac Cardiovasc Surg;1994,108 (2) :321.
  • 4Okada M, Tsubota N, Yoshimru M, et al. Proposal for reasonable mediastinal lymphadenectomy in bronchogenic carcinoma: role of subcarinal node in Selective dissection[J]. J Thorae Cardiovasc Surg, 1998,116 (6) :949.
  • 5吴一龙,王思愚,黄植蕃,区伟,杨学宁,余辉.Ⅰ~ⅢA期非小细胞肺癌淋巴结清扫范围的前瞻性研究[J].中华肿瘤杂志,2001,23(1):43-45. 被引量:69

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部